大熊制药展示数字健康联盟，但核心事实已在一周前披露且缺少新增商业化金额

Daewoong Pharmaceutical (069620) is accelerating efforts to build a full-cycle healthcare ecosystem spanning prevention and diagnosis through treatment and follow-up care, in partnership with domestic digital healthcare companies.
The company said on the 28th that it presented the "Daewoong Alliance" together with 12 Korean digital healthcare companies at K-Hospital Health Tech Fair (KHF) 2026, held at COEX in Seoul from the 19th to the 21st.
KHF 2026 drew about 400 companies and roughly 23,000 visitors. Daewoong Pharmaceutical set up an exhibition hall spanning 20 booths to showcase digital healthcare technologies and cases of their application in clinical settings. About 700 people attended 34 expert lectures held during the fair.
The Daewoong Alliance is a digital healthcare partnership model designed to link health data from hospitals and daily life to deliver "4P healthcare" — predictive, preventive, precision and participatory. The exhibition was organized along the patient's full care journey, covering prevention and prediction, early diagnosis, treatment, and follow-up care, monitoring and clinical efficiency.
In prevention and prediction, the exhibits included Medical AI's electrocardiogram analysis technology "AiTiA," Arc's fundus imaging-based screening solution for blinding eye diseases, and Promedius' chest X-ray-based osteoporosis risk analysis solution.
In early diagnosis, the alliance showcased TRL's AI-based respiratory diagnostic solution "The SpiroKit" and Sky Labs' ring-type continuous blood pressure device "CART BP Pro." In treatment, exhibits included Hurotics' wearable gait rehabilitation robot "H-Medi" and musculoskeletal digital therapeutic and diagnostic solutions from Everex and OrthoCare.
In follow-up care and clinical efficiency, the companies unveiled Seers Technology's inpatient monitoring platform "ThynC," iKooB's real-time continuous glucose monitoring solution for hospitals "CGM Live," and Puzzle AI's AI voice recognition-based medical records solution "PuzzleGen."
"We were able to show the vision and capabilities of the Daewoong Alliance together with our partner companies," Daewoong Pharmaceutical CEO Lee Chang-jae said. "We will lead the way in building a data-driven total healthcare ecosystem spanning prediction through follow-up care."
Daewoong Pharmaceutical plans to develop the Daewoong Alliance into a core growth engine for its digital healthcare business and expand adoption at hospitals and clinics in Korea, based on adoption and commercialization plans discussed with domestic and overseas hospital officials at the event.